VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Exagen Inc. (XGN) Total Return Calculator with Dividends Reinvested

Exagen Inc.

Popular:

The total return for Exagen Inc. (XGN) stock is -51.87% over the past 12 months. So far it's down 48.84% this year. The 5-year total return is -79.30%, meaning $10,000 invested in XGN stock 5 years ago would be worth $2,070 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in XGN 1 year ago, it would be worth $4,524 today — you'd have lost $5,476.

With Dividends Reinvested$4,524-54.76%

Price Only (No DRIP)$4,524-54.76%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in XGN

1Y$4,813-$5,187 (-51.9%)-51.9% CAGR

3Y$11,032+$1,032 (+10.3%)3.3% CAGR

5Y$2,070-$7,930 (-79.3%)-27.0% CAGR

10Y$1,663-$8,337 (-83.4%)-16.4% CAGR

15Y$1,663-$8,337 (-83.4%)-11.3% CAGR

20Y$1,663-$8,337 (-83.4%)-8.6% CAGR

30Y$1,663-$8,337 (-83.4%)-5.8% CAGR

Exagen Inc. did not pay dividends during this period. Total return = price return.

Loading XGN total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-48.84%	—	-48.84%	—	$5,116
1Y	-51.87%	-51.87%	-51.87%	—	$4,813
3Y	+10.32%	3.33%	+10.32%	—	$11,032
5Y	-79.30%	-27.02%	-79.30%	—	$2,070
10Y	-83.37%	-16.42%	-83.37%	—	$1,663
15Y	-83.37%	-11.27%	-83.37%	—	$1,663
20Y	-83.37%	-8.58%	-83.37%	—	$1,663
30Y	-83.37%	-5.80%	-83.37%	—	$1,663

Risk & Highlights

Best Year+108.12%2024

Worst Year-78.30%2022

Max Drawdown-77.84%2025-10-24 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-40.07%	-40.07%	—	+0.41%	-40.5pp
2025	+96.76%	+96.76%	—	+16.64%	+80.1pp
2024	+108.12%	+108.12%	—	+24.00%	+84.1pp
2023	-19.11%	-19.11%	—	+24.81%	-43.9pp
2022	-78.30%	-78.30%	—	-19.95%	-58.4pp

XGN underperformed the S&P 500 by 83.19pp over the past year (-51.87% vs +31.32%).

Loading summary...

XGN Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
XGNExagen Inc.	$71M	+0.3%	-48.8%	-51.9%	—	+10.3%	-79.3%	-83.4%
CDNACareDx, Inc	$1.1B	+17.5%	+9.4%	+47.7%	—	+155.1%	-71.2%	+380.3%
NTRANatera, Inc.	$29.6B	+5.0%	-6.0%	+38.3%	—	+305.1%	+123.3%	+2147.5%
VCYTVeracyte, Inc.	$3.3B	+27.4%	-2.8%	+34.8%	—	+82.0%	-6.0%	+669.9%
CSTLCastle Biosciences, Inc.	$750M	+0.1%	-35.8%	+48.9%	—	+9.3%	-56.0%	+15.7%
MYGNMyriad Genetics, Inc.	$384M	-12.0%	-33.1%	-43.5%	—	-77.6%	-84.7%	-88.0%
EXASExact Sciences Corporation	$20.0B	—	+3.1%	+94.3%	—	+53.0%	-2.9%	+1672.1%
GHGuardant Health, Inc.	$11.5B	+2.9%	-9.3%	+120.0%	—	+292.1%	-31.5%	+186.5%
FLGTFulgent Genetics, Inc.	$444M	-9.1%	-41.7%	-20.7%	—	-54.9%	-79.6%	+62.5%
PGNYProgyny, Inc.	$1.5B	+11.4%	-27.4%	-19.9%	—	-46.3%	-64.1%	+17.3%
LHLabcorp Holdings Inc.	$21.1B	-6.4%	+2.4%	+6.5%	+1.2pp	+38.8%	+12.2%	+150.9%

Compare:XGN vs CDNA XGN vs NTRA XGN vs VCYT XGN vs CDNA vs NTRA

About XGN Dividend Returns

Exagen Inc. (XGN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of XGN over the past year?

Exagen Inc. (XGN) delivered a return of -51.87% over the past year. Since XGN does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in XGN be worth today?

A $10,000 investment in Exagen Inc. one year ago would be worth $4,813 today, representing a loss of $5,187.

Q3Does XGN pay dividends?

Exagen Inc. (XGN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For XGN, the total return equals the price-only return.

Q4Did XGN beat the S&P 500?

No, Exagen Inc. (XGN) underperformed the S&P 500 by 83.19 percentage points over the past year. XGN delivered a total return of -51.87%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed XGN by 83.19pp during this period.

Q5What is XGN's worst drawdown?

Exagen Inc. (XGN) experienced a maximum drawdown of -77.84% over the past year, declining from its peak on 2025-10-24 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is XGN's long-term total return over 10, 20, or 30 years?

Here are Exagen Inc. (XGN)'s long-term returns with dividends reinvested. Over 10 years, the total return is -83.4% (-16.4% CAGR) — $10,000 would have grown to $1,663. Over 20 years: -83.4% total return (-8.6% CAGR) — $10,000 → $1,663. Over 30 years: -83.4% total return (-5.8% CAGR) — $10,000 → $1,663. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was XGN's best and worst year?

Exagen Inc.'s best calendar year was 2024 with a total return of 108.1%. Its worst year was 2022 with a total return of -78.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 186.4 percentage points.